A 44-year-old Caucasian male affected by SCZ presented wide fluctuations in his leukocyte counts documented over a seven-year period. The medical history was significant for co-morbid chronic obstructive pulmonary disease (COPD) and diabetes mellitus type 2 (DMT 2). Apart from clozapine, his pharmacotherapy comprised atenolol, atorvastatin and alprazolam.
A 57-year-old Caucasian female with a diagnosis of SCZ and mild intellectual disability presented frequent fluctuations in the leukocyte counts, with values ranging from normal to moderately elevated. Her past medical history was significant for a diagnosis of epilepsy. Along with clozapine, her pharmacotherapy comprised gabapentin, fenobarbital, biperidene, risperidone and clonazepam.